WEKO3
アイテム
ABO-Incompatible Kidney Transplantation : The Surprising Absence of Hyperacute Rejection
http://hdl.handle.net/10129/4864
http://hdl.handle.net/10129/48644866caf5-d6a7-493f-b4bd-39614d04e1b6
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
HirosakiMedJ_64_S28.pdf (2.2 MB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||||
|---|---|---|---|---|---|---|---|---|
| 公開日 | 2013-04-30 | |||||||
| タイトル | ||||||||
| タイトル | ABO-Incompatible Kidney Transplantation : The Surprising Absence of Hyperacute Rejection | |||||||
| 言語 | ||||||||
| 言語 | eng | |||||||
| キーワード | ||||||||
| 主題Scheme | Other | |||||||
| 主題 | ABO-incompatiblity | |||||||
| キーワード | ||||||||
| 主題Scheme | Other | |||||||
| 主題 | kidney transplantation | |||||||
| キーワード | ||||||||
| 主題Scheme | Other | |||||||
| 主題 | hyperacute rejection | |||||||
| キーワード | ||||||||
| 主題Scheme | Other | |||||||
| 主題 | accommodation | |||||||
| キーワード | ||||||||
| 主題Scheme | Other | |||||||
| 主題 | antibody-mediated rejection | |||||||
| 資源タイプ | ||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||
| 資源タイプ | journal article | |||||||
| 著者 |
Takahashi, Kota
× Takahashi, Kota
|
|||||||
| 著者(ヨミ) | ||||||||
| 識別子Scheme | WEKO | |||||||
| 識別子 | 13774 | |||||||
| 姓名 | タカハシ, コウタ | |||||||
| 著者所属 | ||||||||
| Division of Urology, Dept. of Transplant and Regenerative Medicine, Graduate School of Medical and Dental Sciences, Niigata University | ||||||||
| 抄録 | ||||||||
| 内容記述タイプ | Abstract | |||||||
| 内容記述 | Owing to the shortage of deceased donors in Japan, since 1989, we have performed ABO-incompatible kidney transplantation（ABO-IKTx） to expand the indication for living donor kidney transplantation. During the past 2 decades, about 2,000 ABO-IKTxs were performed. Since 2001 the success rate for these kidney transplants has reached 96% for 1-year graft survival and 91% for 5-year graft survival, similar to outcomes of ABO-compatible kidney transplantation （ABO-CKTx）. This dramatic improvement in results means that ABO-IKTx has become accepted as a therapeutic alternative for end-stage renal failure. Today ABO-IKTx accounts for 30% of all living donor kidney transplantations performed in Japan. In 1901 Karl Landsteiner discovered the presence of human ABO blood groups, and for many years ABO-IKTx was considered contraindicated, as the medical community assumed that this procedure would result in immediate/hyperacute ABO-related rejection followed by graft loss. When we actually attempted the procedure, however, we found that acute antibody-mediated rejection（ AMR）developed, but not a single instance of ABO-related hyperacute rejection. This phenomenon can be demonstrated epidemiologically. Yet, that does not answer the fundamental question of "Why is hyperacute rejection absent?" This article addresses potential mechanisms of acute AMR across ABO mismatched barriers as well as summarizing graft/patient survival of ABO-IKTxs in Japan. |
|||||||
| 引用 | ||||||||
| 内容記述タイプ | Other | |||||||
| 内容記述 | 弘前医学. 64(Suppl.), 2013, p.S28-S44 | |||||||
| 書誌情報 |
弘前医学 巻 64, 号 Supplement, p. S28-S44, 発行日 2013-04-02 |
|||||||
| ISSN | ||||||||
| 収録物識別子タイプ | ISSN | |||||||
| 収録物識別子 | 0439-1721 | |||||||
| 書誌レコードID | ||||||||
| 収録物識別子タイプ | NCID | |||||||
| 収録物識別子 | AN00211444 | |||||||
| 著者版フラグ | ||||||||
| 出版タイプ | VoR | |||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||
| 日本十進分類法 | ||||||||
| 主題Scheme | NDC | |||||||
| 主題 | 490 | |||||||
| NIIサブジェクト | ||||||||
| 主題Scheme | Other | |||||||
| 主題 | 医学 | |||||||
| 出版者 | ||||||||
| 出版者 | 弘前大学大学院医学研究科・弘前医学会 | |||||||
| 資源タイプ | ||||||||
| 値 | Article | |||||||
